|
US4444887A
(en)
|
1979-12-10 |
1984-04-24 |
Sloan-Kettering Institute |
Process for making human antibody producing B-lymphocytes
|
|
US5110587A
(en)
|
1981-12-24 |
1992-05-05 |
Health Research, Incorporated |
Immunogenic composition comprising synthetically modified vaccinia virus
|
|
US5174993A
(en)
|
1981-12-24 |
1992-12-29 |
Health Research Inc. |
Recombinant avipox virus and immunological use thereof
|
|
US4722848A
(en)
|
1982-12-08 |
1988-02-02 |
Health Research, Incorporated |
Method for immunizing animals with synthetically modified vaccinia virus
|
|
US5833975A
(en)
|
1989-03-08 |
1998-11-10 |
Virogenetics Corporation |
Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
|
|
US4769330A
(en)
|
1981-12-24 |
1988-09-06 |
Health Research, Incorporated |
Modified vaccinia virus and methods for making and using the same
|
|
US4603112A
(en)
|
1981-12-24 |
1986-07-29 |
Health Research, Incorporated |
Modified vaccinia virus
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US4716111A
(en)
|
1982-08-11 |
1987-12-29 |
Trustees Of Boston University |
Process for producing human antibodies
|
|
ZA836080B
(en)
|
1982-08-23 |
1984-04-25 |
Scripps Clinic Res |
Broad spectrum influenza antisera
|
|
US4693981A
(en)
|
1983-12-20 |
1987-09-15 |
Advanced Genetics Research Institute |
Preparation of inactivated viral vaccines
|
|
US5106619A
(en)
|
1983-12-20 |
1992-04-21 |
Diamond Scientific Co. |
Preparation of inactivated viral vaccines
|
|
FR2583429B1
(fr)
|
1985-06-18 |
1989-11-03 |
Transgene Sa |
Vecteur d'expression de l'interferon u dans les cellules de mammifere, procede pour sa mise en oeuvre et produit obtenu et composition pharmaceutique contenant l'interferon u
|
|
US5182192A
(en)
|
1987-03-27 |
1993-01-26 |
The Wistar Institute |
Monoclonal antibodies against glycolipid antigens, methods of producing these antibodies, and use therefor
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US5413923A
(en)
|
1989-07-25 |
1995-05-09 |
Cell Genesys, Inc. |
Homologous recombination for universal donor cells and chimeric mammalian hosts
|
|
US5166057A
(en)
|
1989-08-28 |
1992-11-24 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand rna virus expression-systems
|
|
US5854037A
(en)
|
1989-08-28 |
1998-12-29 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand RNA virus expression systems and vaccines
|
|
US6001634A
(en)
|
1989-08-28 |
1999-12-14 |
Palese; Peter |
Recombinant negative strand RNA viruses
|
|
EP1690935A3
(en)
|
1990-01-12 |
2008-07-30 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
US6887699B1
(en)
|
1990-05-22 |
2005-05-03 |
Medimmune Vaccines, Inc. |
Recombinant negative strand RNA virus expression systems and vaccines
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
FR2664905B1
(fr)
*
|
1990-07-18 |
1994-08-12 |
Agronomique Inst Nat Rech |
Baculovirus modifie, son procede d'obtention, et vecteurs d'expression obtenus a partir dudit baculovirus.
|
|
ES2246502T3
(es)
|
1990-08-29 |
2006-02-16 |
Genpharm International, Inc. |
Animales no humanos transgenicos capaces de producir anticuerpos heterologos.
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US6034298A
(en)
|
1991-08-26 |
2000-03-07 |
Prodigene, Inc. |
Vaccines expressed in plants
|
|
US5612487A
(en)
|
1991-08-26 |
1997-03-18 |
Edible Vaccines, Inc. |
Anti-viral vaccines expressed in plants
|
|
US5484719A
(en)
|
1991-08-26 |
1996-01-16 |
Edible Vaccines, Inc. |
Vaccines produced and administered through edible plants
|
|
PT1024191E
(pt)
|
1991-12-02 |
2008-12-22 |
Medical Res Council |
Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
|
|
US6337070B1
(en)
|
1993-04-29 |
2002-01-08 |
Takara Shuzo Co., Ltd. |
Polypeptides for use in generating anti-human influenza virus antibodies
|
|
EP0621339B1
(en)
|
1992-09-17 |
2001-10-24 |
Takara Shuzo Co. Ltd. |
Immunogenic human influenza A virus haemagglutinin polypeptides
|
|
US5589174A
(en)
*
|
1992-09-17 |
1996-12-31 |
Takara Shuzo Co., Ltd. |
Anti-human influenza virus antibody
|
|
JP3037554B2
(ja)
|
1993-04-20 |
2000-04-24 |
寳酒造株式会社 |
免疫原性人工ポリペプチド
|
|
GB9221654D0
(en)
|
1992-10-15 |
1992-11-25 |
Scotgen Ltd |
Recombinant human anti-cytomegalovirus antibodies
|
|
AU6014094A
(en)
|
1992-12-02 |
1994-06-22 |
Baylor College Of Medicine |
Episomal vectors for gene therapy
|
|
WO1994016109A1
(en)
|
1993-01-15 |
1994-07-21 |
Whitehead Institute For Biomedical Research |
Membrane fusion events and means for altering same
|
|
WO1994017826A1
(en)
|
1993-02-01 |
1994-08-18 |
Smithkline Beecham Corporation |
Vaccinal polypeptides
|
|
US5573916A
(en)
|
1994-05-19 |
1996-11-12 |
Coretech, Inc. |
Immunogenic constructs comprising b-cell and t-cell epitopes on common carrier
|
|
US5505947A
(en)
|
1994-05-27 |
1996-04-09 |
The University Of North Carolina At Chapel Hill |
Attenuating mutations in Venezuelan Equine Encephalitis virus
|
|
US5622701A
(en)
|
1994-06-14 |
1997-04-22 |
Protein Design Labs, Inc. |
Cross-reacting monoclonal antibodies specific for E- and P-selectin
|
|
DK0702085T4
(da)
|
1994-07-18 |
2010-04-06 |
Conzelmann Karl Klaus Prof Dr |
Rekombinant infektiøs ikke-segmenteret negativ-strenget RNA-virus
|
|
CA2201592A1
(en)
|
1994-10-03 |
1996-04-18 |
The Government Of The United States Of America, Represented By The Secre Tary, Department Of Health And Human Services |
Enhanced immune response by introduction of cytokine gene and/or costimulatory molecule b7 gene in a recombinant virus expressing system
|
|
CA2219361C
(en)
|
1995-04-27 |
2012-02-28 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
WO1996034096A1
(en)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US7153510B1
(en)
|
1995-05-04 |
2006-12-26 |
Yale University |
Recombinant vesiculoviruses and their uses
|
|
EP0780475B2
(en)
|
1995-08-09 |
2006-07-19 |
SCHWEIZ. SERUM- & IMPFINSTITUT BERN |
Process for the production of infectious negative-strand RNA viruses
|
|
US6264957B1
(en)
|
1995-09-27 |
2001-07-24 |
The United States Of America As Represented By The Department Of Health And Human Services |
Product of infectious respiratory syncytial virus from cloned nucleotide sequences
|
|
JP2820106B2
(ja)
|
1996-02-29 |
1998-11-05 |
日本電気株式会社 |
トラヒックシェーパ装置
|
|
WO1997040161A1
(en)
*
|
1996-04-19 |
1997-10-30 |
Henry M. Jackson Foundation For The Advancement Of Military Medecine |
Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
|
|
JP2000510332A
(ja)
|
1996-04-19 |
2000-08-15 |
ヘンリー エム．ジャクソン ファンデーション フォー ザ アドバンスメント オブ ミリタリー メディシン |
インチミンを単独で、または１以上の他の抗原との融合タンパク質として発現する宿主生物の投与による、免疫応答を刺激する方法
|
|
EP0912724B1
(en)
|
1996-07-15 |
2009-12-09 |
The Government of The United States of America, as represented by The Department of Health and Human Services |
Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
|
|
US20050032211A1
(en)
|
1996-09-26 |
2005-02-10 |
Metabogal Ltd. |
Cell/tissue culturing device, system and method
|
|
IL155588A0
(en)
|
2003-04-27 |
2003-11-23 |
Metabogal Ltd |
Methods for expression of enzymatically active recombinant lysosomal enzymes in transgenic plant root cells and vectors used thereby
|
|
WO1998013501A2
(en)
|
1996-09-27 |
1998-04-02 |
American Cyanamid Company |
3' genomic promoter region and polymerase gene mutations responsible for attenuation in viruses of the order designated mononegavirales
|
|
US5916771A
(en)
|
1996-10-11 |
1999-06-29 |
Abgenix, Inc. |
Production of a multimeric protein by cell fusion method
|
|
EP1972194A1
(en)
|
1996-12-03 |
2008-09-24 |
Amgen Fremont Inc. |
Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom
|
|
US5891705A
(en)
|
1997-04-08 |
1999-04-06 |
Pentose Pharmaceuticals, Inc. |
Method for inactivating a virus
|
|
JP3876002B2
(ja)
|
1997-04-14 |
2007-01-31 |
ミクロメート・アクチエンゲゼルシャフト |
抗ヒト抗原受容体を産生するための斬新な方法およびそれらの使用
|
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
|
DE69842165D1
(de)
|
1997-05-23 |
2011-04-21 |
Us Of America As Represented By The Secretary Of The Dept Of Health And Human Services |
Herstellung attenuierter parainfluenza-virus impfstoffe aus klonierten nukleotidsequenzen
|
|
US6165476A
(en)
|
1997-07-10 |
2000-12-26 |
Beth Israel Deaconess Medical Center |
Fusion proteins with an immunoglobulin hinge region linker
|
|
DE69837764T2
(de)
|
1997-07-11 |
2008-01-31 |
Yale University, New Haven |
Rhabdovirus mit gentechnisch veränderter hülle
|
|
KR20010030630A
(ko)
|
1997-09-19 |
2001-04-16 |
윌리암 에이취 캘넌, 에곤 이 버그 |
약독화 호흡 신시티아 바이러스
|
|
DE69937999T2
(de)
|
1998-06-12 |
2009-01-29 |
Avir Green Hills Biotechnology Research Development Trade Ag |
Interferon induzierende genetisch veränderte attenuierte viren
|
|
SK288544B6
(sk)
|
1998-06-12 |
2018-03-05 |
Mount Sinai School Of Medicine |
Geneticky skonštruovaný oslabený chimérny vírus chrípky, vakcinačný prostriedok a farmaceutický prostriedok s jeho obsahom a ich použitie
|
|
US6544785B1
(en)
|
1998-09-14 |
2003-04-08 |
Mount Sinai School Of Medicine Of New York University |
Helper-free rescue of recombinant negative strand RNA viruses
|
|
US6146642A
(en)
|
1998-09-14 |
2000-11-14 |
Mount Sinai School Of Medicine, Of The City University Of New York |
Recombinant new castle disease virus RNA expression systems and vaccines
|
|
MXPA01006491A
(es)
|
1998-12-23 |
2003-06-06 |
Thompson Boyce Plant Res |
Expresion de antigenos de superficie de hepatitis b inmunogenicos en plantas transgenicas.
|
|
AT407958B
(de)
|
1999-02-11 |
2001-07-25 |
Immuno Ag |
Inaktivierte influenza-virus-vakzine zur nasalen oder oralen applikation
|
|
MXPA01010921A
(es)
|
1999-04-29 |
2003-06-24 |
Syngenta Ltd |
Plantas resistentes a herbicidas.
|
|
DE122007000070I1
(de)
|
1999-07-14 |
2008-01-31 |
Sinai School Medicine |
In Vitro-rekonstitution von segmentierten Negativstrang-Rna-Viren
|
|
PL355287A1
(en)
|
1999-09-24 |
2004-04-05 |
Smithkline Beecham Biologicals S.A. |
Intranasal influenza virus vaccine
|
|
US7521220B2
(en)
|
1999-11-26 |
2009-04-21 |
Crucell Holland B.V. |
Production of vaccines
|
|
US6770799B2
(en)
|
2000-03-17 |
2004-08-03 |
Thompson Boyce Plant Res |
Expression of recombinant human acetylcholinesterase in transgenic plants
|
|
AU5921101A
(en)
|
2000-04-28 |
2001-11-12 |
St Jude Childrens Res Hospital |
Dna transfection system for the generation of infectious influenza virus
|
|
US6632620B1
(en)
|
2000-06-22 |
2003-10-14 |
Andrew N. Makarovskiy |
Compositions for identification and isolation of stem cells
|
|
EP3009507B1
(en)
|
2002-02-13 |
2020-06-24 |
Wisconsin Alumini Research Foundation |
Signal for packaging of influenza virus vectors
|
|
US20040091503A1
(en)
*
|
2002-08-20 |
2004-05-13 |
Genitrix, Llc |
Lectin compositions and methods for modulating an immune response to an antigen
|
|
WO2004067553A2
(en)
|
2003-01-29 |
2004-08-12 |
The Research Foundation Of The State University Of New York |
Tolerance-induced targeted antibody production
|
|
CA2514667C
(en)
|
2003-01-30 |
2013-01-08 |
Chiron Corporation |
Adjuvanted influenza vaccine
|
|
US7695725B2
(en)
|
2003-02-06 |
2010-04-13 |
Aduro Biotech |
Modified free-living microbes, vaccine compositions and methods of use thereof
|
|
JP4368594B2
(ja)
|
2003-02-24 |
2009-11-18 |
株式会社インシリコサイエンス |
タンパク質構造予測装置、タンパク質構造予測方法、プログラム、および、記録媒体
|
|
US7951557B2
(en)
|
2003-04-27 |
2011-05-31 |
Protalix Ltd. |
Human lysosomal proteins from plant cell culture
|
|
KR20060035596A
(ko)
|
2003-05-05 |
2006-04-26 |
보이스 톰슨 인스터튜트 포 플랜트 리서치 |
외래유전자도입 식물로부터 유래된 면역보호성 조성물을제조하기 위한 벡터와 세포
|
|
WO2004104198A1
(ja)
|
2003-05-26 |
2004-12-02 |
Toray Industries, Inc. |
遺伝子型2aのC型肝炎ウイルス（HCV）ゲノム由来の核酸を含む核酸構築物、及び該核酸構築物を導入した細胞
|
|
US8592197B2
(en)
*
|
2003-07-11 |
2013-11-26 |
Novavax, Inc. |
Functional influenza virus-like particles (VLPs)
|
|
PL1692265T3
(pl)
|
2003-11-04 |
2011-12-30 |
The Administrators Of The Tulane Educational Fund |
Sposób zapobiegania fuzji wirus:komórka przez hamowanie działania regionu inicjowania fuzji w wirusach RNA zawierających fuzogenne błonowe białka otoczki klasy I
|
|
WO2005116260A2
(en)
*
|
2004-05-25 |
2005-12-08 |
Medimmune Vaccines, Inc. |
Influenza hemagglutinin and neuraminidase variants
|
|
KR20070085291A
(ko)
|
2004-10-13 |
2007-08-27 |
프로탈릭스 리미티드 |
식물 세포 배양에서 항체를 생산하는 시스템 및 방법
|
|
EP1851238A4
(en)
|
2005-02-24 |
2008-12-31 |
Univ Massachusetts |
FLUID NUCLEIC ACIDS, POLYPEPTIDES AND USES THEREOF
|
|
EP2963118B1
(en)
|
2005-06-01 |
2017-08-09 |
California Institute of Technology |
Method of targeted gene delivery using viral vectors
|
|
JP4758148B2
(ja)
|
2005-06-14 |
2011-08-24 |
泰三 宇田 |
インフルエンザウイルスのヘマグルチニンに対する抗体酵素
|
|
US7951384B2
(en)
|
2005-08-05 |
2011-05-31 |
University Of Massachusetts |
Virus-like particles as vaccines for paramyxovirus
|
|
US20070064857A1
(en)
|
2005-08-19 |
2007-03-22 |
Winterberg Friedwardt M |
Thermonuclear plasma confinement with thermomagnetic currents generated by nuclear reactions from fusion neutrons
|
|
US8098789B2
(en)
|
2005-09-09 |
2012-01-17 |
Wisconsin Alumni Research Foundation |
Systems and methods for the cyclotron production of iodine-124
|
|
US8662363B2
(en)
|
2005-09-27 |
2014-03-04 |
Dennis Williams |
Golf car accessory
|
|
ES2377884T3
(es)
|
2005-11-04 |
2012-04-02 |
Novartis Vaccines And Diagnostics S.R.L. |
Vacunas contra la gripe que incluyen combinaciones de adyuvantes particulados e inmunopotenciadores
|
|
JP5603012B2
(ja)
|
2005-12-02 |
2014-10-08 |
トヘ モウント シナイ スクール オフ メディシネ オフ ニューヨーク ウニベルシトイ |
非天然表面タンパク質を提示するキメラウイルス及びその使用
|
|
DK1968632T3
(da)
|
2005-12-06 |
2012-07-16 |
Yeda Res & Dev |
Forbedret influenzavaccine
|
|
US10183986B2
(en)
|
2005-12-15 |
2019-01-22 |
Industrial Technology Research Institute |
Trimeric collagen scaffold antibodies
|
|
US8124103B2
(en)
|
2006-02-13 |
2012-02-28 |
Fraunhofer Usa, Inc |
Influenza antigens, vaccine compositions, and related methods
|
|
US20070207171A1
(en)
|
2006-03-01 |
2007-09-06 |
Cerus Corporation |
Engineered listeria and methods of use thereof
|
|
ES2555544T3
(es)
|
2006-03-07 |
2016-01-04 |
Vaxinnate Corporation |
Composiciones que incluyen hemaglutinina, métodos de preparación y métodos de uso de las mismas
|
|
ATE539079T1
(de)
|
2006-03-23 |
2012-01-15 |
Novartis Ag |
Imidazochinoxalinverbindungen als immunmodulatoren
|
|
CA2646891A1
(en)
|
2006-03-23 |
2007-09-27 |
Novartis Ag |
Immunopotentiating compounds
|
|
WO2007110776A1
(en)
|
2006-03-24 |
2007-10-04 |
Novartis Vaccines And Diagnostics Gmbh & Co Kg |
Storage of influenza vaccines without refrigeration
|
|
US20070262178A1
(en)
|
2006-05-12 |
2007-11-15 |
Ultradent Products, Inc. |
Syringe delivery tip including an enlarged flocked wing element adjacent a distal delivery end
|
|
US8148085B2
(en)
*
|
2006-05-15 |
2012-04-03 |
Sea Lane Biotechnologies, Llc |
Donor specific antibody libraries
|
|
JP2009537147A
(ja)
|
2006-05-15 |
2009-10-29 |
シー レーン バイオテクノロジーズ， エルエルシー |
インフルエンザウイルスに対する中和抗体
|
|
EP2023952B1
(en)
*
|
2006-05-18 |
2015-07-15 |
Epimmune Inc. |
Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions
|
|
EP2035565A4
(en)
|
2006-06-30 |
2010-07-21 |
Novavax Inc |
METHODS OF ENHANCING THE INCORPORATION OF PROTEINS IN VIRUS-LIKE PARTICLES (VLPs)
|
|
WO2008011636A2
(en)
|
2006-07-21 |
2008-01-24 |
California Institute Of Technology |
Targeted gene delivery for dendritic cell vaccination
|
|
CA2663388C
(en)
|
2006-09-07 |
2017-01-17 |
Crucell Holland B.V. |
Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof
|
|
NZ575271A
(en)
|
2006-09-11 |
2011-09-30 |
Novartis Ag |
Making influenza virus vaccines without using eggs
|
|
US20080075998A1
(en)
|
2006-09-22 |
2008-03-27 |
Tatsumi Ishihara |
Electrolyte membrane for electrochemical cell and a method of producing the same
|
|
US20080085876A1
(en)
|
2006-10-05 |
2008-04-10 |
Schwartz David L |
Insect sting treatment
|
|
CN103254308B
(zh)
|
2007-06-15 |
2015-01-21 |
厦门大学 |
H5亚型禽流感病毒血凝素蛋白的单克隆抗体或其结合活性片段及其用途
|
|
EP2014279A1
(en)
|
2007-06-22 |
2009-01-14 |
Pevion Biotech AG |
Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof
|
|
PT2185191E
(pt)
|
2007-06-27 |
2012-11-27 |
Novartis Ag |
Vacinas contra a gripe com baixo teor de aditivos
|
|
CA2615372A1
(en)
|
2007-07-13 |
2009-01-13 |
Marc-Andre D'aoust |
Influenza virus-like particles (vlps) comprising hemagglutinin
|
|
WO2009076778A1
(en)
|
2007-11-27 |
2009-06-25 |
Medicago Inc. |
Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
|
|
US20090092635A1
(en)
|
2007-08-17 |
2009-04-09 |
Wyeth |
Heterologous prime-boost immunization regimen
|
|
EP2200639B1
(en)
|
2007-09-24 |
2016-03-30 |
Government of the USA, as Represented by the Secretary, Department of Health and Human Services |
Immunostimulatory combinations of tlr3 ligands with tlr2 and tlr9 agonists and methods of use
|
|
FR2921387B1
(fr)
*
|
2007-09-26 |
2012-04-20 |
Sanofi Pasteur |
Procede de production du virus de la grippe
|
|
GB0810305D0
(en)
|
2008-06-05 |
2008-07-09 |
Novartis Ag |
Influenza vaccination
|
|
EP3524619A1
(en)
|
2007-12-06 |
2019-08-14 |
Dana-Farber Cancer Institute, Inc. |
Antibodies against influenza virus and methods of use thereof
|
|
WO2009092038A1
(en)
|
2008-01-16 |
2009-07-23 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Influenza dna vaccination and methods of use thereof
|
|
ITTO20080204A1
(it)
|
2008-03-17 |
2009-09-18 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali atti a reagire con una pluralita di sottotipi del virus influenzale a
|
|
CA2719201A1
(en)
|
2008-03-28 |
2009-10-01 |
Sea Lane Biotechnologies, Llc. |
Neutralizing molecules to viral antigens
|
|
GB0905570D0
(en)
|
2009-03-31 |
2009-05-13 |
Novartis Ag |
Combined vaccines
|
|
EP2310409A2
(en)
|
2008-06-17 |
2011-04-20 |
Apogenix GmbH |
Multimeric tnf receptors
|
|
WO2010003235A1
(en)
|
2008-07-08 |
2010-01-14 |
Medicago Inc. |
Soluble recombinant influenza antigens
|
|
US20110177122A1
(en)
|
2008-09-26 |
2011-07-21 |
The United States Of America, As Represented By The Secretary, Dept. Of Health & Human Services |
Dna prime/activated vaccine boost immunization to influenza virus
|
|
CA2787099A1
(en)
|
2009-03-30 |
2010-10-14 |
Anice C. Lowen |
Influenza virus hemagglutinin polypeptides containing stem domains, vaccines and uses thereof
|
|
KR101790354B1
(ko)
|
2009-05-11 |
2017-10-25 |
얀센 백신스 앤드 프리벤션 비.브이. |
인플루엔자 바이러스 ｈ3ｎ2를 중화시킬 수 있는 인간 결합 분자 및 그것의 용도
|
|
JP5941841B2
(ja)
*
|
2009-05-26 |
2016-06-29 |
アイカーン スクール オブ メディシン アット マウント サイナイ |
周期的投与によって作製されたインフルエンザウイルスに対するモノクローナル抗体及びその使用
|
|
BRPI1015053A2
(pt)
|
2009-06-24 |
2019-07-09 |
Medicago Inc |
partículas similares a vírus da influenza quiméricas compreendendo hemaglutinina
|
|
US8828406B2
(en)
|
2009-07-30 |
2014-09-09 |
Icahn School Of Medicine At Mount Sinai |
Influenza viruses and uses thereof
|
|
JP5463107B2
(ja)
|
2009-09-14 |
2014-04-09 |
独立行政法人国立国際医療研究センター |
新型インフルエンザを特異的に鑑別するモノクローナル抗体とそれを利用した免疫検出試薬
|
|
US20120219584A1
(en)
|
2009-10-05 |
2012-08-30 |
The United States Of America As Represented By The Secretary, Department Of Health |
Protection against pandemic and seasonal strains of influenza
|
|
JP2013060367A
(ja)
|
2010-01-15 |
2013-04-04 |
Osaka Univ |
抗インフルエンザ抗体及びインフルエンザ検出用デバイス
|
|
US8298820B2
(en)
|
2010-01-26 |
2012-10-30 |
The Trustees Of The University Of Pennsylvania |
Influenza nucleic acid molecules and vaccines made therefrom
|
|
US9701723B2
(en)
|
2010-02-18 |
2017-07-11 |
Icahn School Of Medicine At Mount Sinai |
Vaccines for use in the prophylaxis and treatment of influenza virus disease
|
|
CN102791734B
(zh)
|
2010-03-08 |
2014-10-15 |
赛特瑞恩股份有限公司 |
源自人b细胞且具有抗甲型流感病毒的中和活性的人单克隆抗体
|
|
WO2011123495A1
(en)
|
2010-03-30 |
2011-10-06 |
Mount Sinai School Of Medicine |
Influenza virus vaccines and uses thereof
|
|
US9707288B2
(en)
|
2010-07-22 |
2017-07-18 |
John W. Schrader |
Cross-protective pathogen protection, methods and compositions thereof
|
|
EP2758075B1
(en)
|
2011-09-20 |
2023-05-03 |
Icahn School of Medicine at Mount Sinai |
Influenza virus vaccines and uses thereof
|
|
IN2014CN04742A
(enExample)
|
2011-11-28 |
2015-09-18 |
Crucell Holland Bv |
|
|
CA2894506C
(en)
|
2012-12-11 |
2021-08-10 |
Vib Vzw |
Anti-influenza antibody
|
|
EP2934581B1
(en)
|
2012-12-18 |
2022-09-14 |
Icahn School of Medicine at Mount Sinai |
Influenza virus vaccines and uses thereof
|
|
IL241552B2
(en)
|
2013-03-14 |
2023-09-01 |
Contrafect Corp |
Preparation and methods based on neutralizing antibodies administered intranasally for increased therapeutic efficacy
|
|
US9908930B2
(en)
|
2013-03-14 |
2018-03-06 |
Icahn School Of Medicine At Mount Sinai |
Antibodies against influenza virus hemagglutinin and uses thereof
|
|
KR102463632B1
(ko)
|
2014-07-10 |
2022-11-03 |
얀센 백신스 앤드 프리벤션 비.브이. |
인플루엔자 바이러스 백신 및 이의 용도
|
|
WO2016005480A1
(en)
|
2014-07-10 |
2016-01-14 |
Crucell Holland B.V. |
Influenza virus vaccines and uses thereof
|